Cargando...
Major histocompatibility complex Class II-based therapy for stroke
This review discusses the potential of major histocompatibility complex (MHC) Class II constructs as stroke therapeutics. We focus on the delivery of MHC Class II construct, DRmQ, as a safe and effective treatment for ischemic stroke. DRmQ was observed to attenuate behavioral deficits and decrease m...
Guardado en:
| Publicado en: | Brain Circ |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8057100/ https://ncbi.nlm.nih.gov/pubmed/34084976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/bc.bc_16_21 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|